You are here

CMS

Roche yields to cancer biosim competition by offering 'relevant' discounts: report

Fierce Pharma

Thu, 12/10/20 - 07:19 pm

CMS to pay less for Covid-19 test results that take longer than two days

MedCity News

Mon, 10/19/20 - 11:14 pm

Boston Scientific stent gains added Medicare coverage

Mass Device

Fri, 09/4/20 - 10:28 am

Boston Scientific

drug-eluting vascular stents

CMS proposes 1.6% inpatient increase and new CAR-T cell therapy payment

Healthcare Finance News

Tue, 05/12/20 - 10:13 pm

Good News for COVID-19 Testing Companies: Medicare Nearly Doubles Reimbursement

Motley Fool

Fri, 04/17/20 - 10:53 am

The Latest CMS Outlook for Drug Spending—And How COVID-19 Will Change It

Drug Channels

Tue, 04/7/20 - 10:12 am

CMS delays clinical lab fee schedule data reporting, cuts capped at 15% for 2021

Medtech Dive

Sun, 01/5/20 - 07:13 pm

clinical laboratory fees

Latest CMS Data: Drug Spending is Not Skyrocketing; Hospitals and Physicians Dominate Healthcare Costs

Drug Channels

Tue, 12/10/19 - 10:29 am

CMS proposes lifting restrictions on NGS cancer testing

Biopharma Dive

Thu, 10/31/19 - 10:39 am

next generation sequencing

Preferred Pharmacy Networks Rebound in 2020 Medicare Part D Plans: Details on WellCare, CVS Health, Humana, Cigna, and More

Drug Channels

Tue, 10/22/19 - 11:00 pm

Medicare Part D

preferred pharmacy networks

CMS to cover CAR-T therapy nationwide

Beckers Hospital Review

Thu, 08/8/19 - 10:53 am

CMS prescribes payment fix to resuscitate US antibiotic industry

Endpoints

Mon, 08/5/19 - 11:11 am

drug development

Pharma shells out $3B to doctors and hospitals—with Roche, Sanofi leading: CMS

Fierce Pharma

Mon, 07/1/19 - 12:06 pm

physician payments

CMS approves Louisiana's 'Netflix model' with Gilead for hepatitis C drugs

Biopharma Dive

Wed, 06/26/19 - 11:49 pm

Gilead Sciences

Federal Court Punts Regarding Remedy Related to CMS’ Invalidated Rule Concerning Medicare Hospital Outpatient Payment Rates for 340B Drugs

FDA Law Blog

Fri, 05/17/19 - 07:16 pm

CMS reopens coverage determination on next-gen sequencing for cancer patients

Medtech Dive

Tue, 04/30/19 - 09:43 pm

next generation sequencing

How a Medicare Rule Change Could Bring CAR-T Stocks Back to Life

Motley Fool

Sat, 04/27/19 - 10:47 am

Gilead Sciences

Medicare proposes raising CAR-T pay, but reimbursement solution years away

Biopharma Dive

Wed, 04/24/19 - 03:58 pm

CMS demo could pave the path to eliminating Part D rebates

BioCentury

Mon, 04/8/19 - 11:18 pm

Medicare Part D

Electronic Health Records: A Promising New Way To Fight the Opioid Epidemic

Forbes

Fri, 03/15/19 - 08:37 pm

Pages